These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Fungal infections in children with malignant disease]. Michel G. Arch Pediatr; 2011 May; 18 Suppl 1():S3-7. PubMed ID: 21596284 [Abstract] [Full Text] [Related]
8. [Systemic mycotic infections]. Meunier F. Recenti Prog Med; 1990 Jan 30; 81(1):18-22. PubMed ID: 2173078 [Abstract] [Full Text] [Related]
9. Treatment of fungal and other opportunistic infections in immunocompromised patients. Wade JC. Leukemia; 1997 May 30; 11 Suppl 4():S38-9. PubMed ID: 9179282 [Abstract] [Full Text] [Related]
10. Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts. Metcalf SC, Dockrell DH. J Infect; 2007 Oct 30; 55(4):287-99. PubMed ID: 17697716 [Abstract] [Full Text] [Related]
11. [Management of visceral mycoses, with special reference to drug therapy]. Ikemoto H. Nihon Rinsho; 1980 Nov 30; 38(11):4386-92. PubMed ID: 7253229 [No Abstract] [Full Text] [Related]
14. [Disseminated Trichosporon asahii infection]. Servonnet A, Bourgault M, Trueba F, Sarret D, Nicand E. Ann Biol Clin (Paris); 2010 Mar 30; 68(3):363-6. PubMed ID: 20478783 [Abstract] [Full Text] [Related]
15. Drug treatment of the systemic mycoses. Newberry WM. Semin Drug Treat; 1972 Mar 30; 2(3):313-29. PubMed ID: 4617926 [No Abstract] [Full Text] [Related]